Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2024Asian Journal of Medical SciencesOpen Access

Silymarin-choline combination versus ursodeoxycholic acid in non-alcoholic fatty liver disease: A randomized double-blind clinical trial

View Full Paper
Ask AI
Bookmark
Share

Authors

PCPurba ChakrabartyMMMayukh MukherjeeRARajasee Adhikary

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chakrabarty et al. (2024) studied this question.

synapsesocial.com/papers/68e7103bb6db643587689de1https://doi.org/10.3126/ajms.v15i4.61970
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy of different interventions for nonalcoholic fatty liver disease: A meta-analysis of lifestyle modifications, silymarin, and medications.2025
  2. 2Effects of Silymarin Combined with Herbal Medicine on Th17/Treg Cell Imbalance and Inflammatory Response in Patients with Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial2025 · 1 citations
  3. 3Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report2023 · 9 citations
  4. 4The impact of choline supplementation on oxidative stress and clinical outcomes among patients with non-alcoholic fatty liver disease: a randomized controlled study2025
  5. 5Sylimarin Versus Essential Phospholipids in Metabolic Associated Steatotic Liver Disease (MASLD) – A Prospective Comparative Randomized Trial2024 · 2 citations